Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

228 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

NCT07519772

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
  • SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
  • Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
View all 22 locations
View Trial Details
Recruiting

A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies

NCT07308132

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Monash Medical Centre Clayton, Australia
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • Macquarie University Hospital North Ryde, Australia
  • Scientia Clinical Research Randwick, Australia
View all 19 locations
View Trial Details
Recruiting

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

NCT07101328

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
View all 50 locations
View Trial Details
Recruiting

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

NCT04935684

Conditions
Acute Leukemia in Remission, Bone Marrow Diseases, Chronic Disease, +27 more
Locations
  • Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud Amiens, France
  • Service Maladies du sang CHU Angers Angers, France
  • Hématologie clinique CHU Besançon Besançon, France
  • Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand Clermont-Ferrand, France
View all 20 locations
View Trial Details
Recruiting

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

NCT04460235

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Chu Angers Angers, France
  • CHU Bordeaux Bordeaux, France
  • CHU Limoges Limoges, France
  • Chu Nantes Nantes, France
View Trial Details
Recruiting

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

NCT02693535

Conditions
Advanced Solid Tumors, Blood Protein Disorders, Cardiovascular Diseases, +16 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Cancer Treatment Centers of America-Phoenix Phoenix, Arizona, United States
  • Sutter Auburn Auburn, California, United States
  • Sutter Alta Bates Berkeley, California, United States
View all 181 locations
View Trial Details

Related conditions